Promising results have been observed for the GLP-1/GIP agonist LY3298176 in overweight or obese people with T2D, noting a weight loss between 0.9 and 11.3 kg in participants using the dual agent compared with 0.4 kg and 2.7 kg in those using placebo or dulaglutide respectively [52]
Though these posts don't claim to offer medical solutions, they reflect a growing sense of self-agencyand a desire to learn what the body may need to feel better naturally
Helps Reduce Oxidative Stress *
No claims are made regarding the safety, efficacy, or suitability of this material outside of a controlled research environment.
Clinicians ask about onset, duration, severity, associated symptoms (fever, cough, runny nose, ear pain), exposures (sick contacts, travel, smoking), and risk factors (immune status, sexual history)
With Semaglutide, you might start to see the scale shift in the first few weeks, and bigger results by month three